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 2 
Abstract 
 
Podosomes represent a class of integrin-mediated cell-matrix adhesions formed by 
migrating and matrix-degrading cells. Here, we demonstrate that in macrophage-
like THP1 cells and in fibroblasts stimulated to produce podosomes, down-
regulation of G protein ARF1 or the ARF1-GEF ARNO by siRNAs or by 
pharmacological inhibitors led to striking podosome elimination. Concomitantly, 
treatments inducing podosome formation increased the level of GTP-bound ARF1. 
ARNO was found to co-localize with the adhesive rings of podosomes while ARF1 
was localized to vesicular structures transiently contacting podosome rings.  
Inhibition of ARF1 led to an increase in RhoA-GTP levels and triggered assembly of 
myosin-IIA filaments in THP1 cells, whilst the suppression of myosin-IIA rescued 
podosome formation regardless of ARF1 inhibition. Finally, expression of 
constitutively active ARF1 in fibroblasts induced formation of putative podosome 
precursors: actin-rich puncta coinciding with matrix degradation sites and 
containing proteins of the podosome core but not of the adhesive ring. Thus, ARNO-
ARF1 regulates formation of podosomes by inhibition of RhoA/myosin-II and 
promotion of actin core assembly.  
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Introduction 
 
Podosomes are a distinctive form of integrin-mediated cell-matrix adhesion typical 
of monocyte-derived cells but under some circumstances are produced by cells of 
other lineages. They usually appear as micron-sized radially symmetrical 
protrusions containing central actin cores (height about ~2 m) rooted in the 
cytoplasm surrounded by matrix-associated “adhesive rings”(~1 m diameter) 
enriched in integrins and plaque proteins such as talin, paxillin, vinculin and Tks5 
(Calle et al., 2006; Cox and Jones, 2013; Labernadie et al., 2014; Meddens et al., 
2014; Murphy and Courtneidge, 2011; Seano et al., 2014; Wiesner et al., 2010). In 
the majority of cell types, podosomes form arrays consisting of numerous individual 
podosomes connected to each other via a mesh of F-actin-containing links 
containing myosin-II (Cox et al., 2012; Dries et al., 2013; Panzer et al., 2016). 
Individual podosome-like structures formed by invasive cancer cells are more 
stable, protrusive and larger in size than normal podosomes and are often termed 
invadopodia (Gimona et al., 2008; Murphy and Courtneidge, 2011). Podosomes 
participate in the processes of cell migration and invasion as well as degradation of 
extracellular matrix via secretion of matrix metalloproteinases (El Azzouzi et al., 
2016; Gawden-Bone et al., 2010; Linder and Wiesner, 2015; Wiesner et al., 2010).  
 
Cells of monocytic origin (for example cultured macrophage-like THP1 cells) form 
numerous podosomes upon stimulation with transforming growth factor beta 
(TGF) or increasing protein kinase C (PKC) activity by phorbol esters (e.g. PMA). 
Moreover, upon appropriate stimulation, even podosome-lacking cells can be forced 
to form podosome-like structures. In particular, expression of constitutively active 
Src in fibroblasts triggers formation of high-order adhesion structures termed 
podosome “rosettes”, which are capable of degrading the ECM (Tarone et al., 1985). 
More recently, we have shown that non-transformed fibroblasts that typically do 
not form podosomes develop podosome-like adhesions under conditions where a 
cell cannot apply strong traction force to nascent integrin clusters, such as 
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spreading on fluid RGD-functionalized lipid bilayers, where stress fibres fail to 
assemble (Yu et al., 2013).  
 
A key process in podosome formation is a local polymerization of actin cores 
primarily mediated by Arp2/3 complex activated by Wiskott–Aldrich Syndrome 
protein (WASP)(Burns et al., 2001; Linder et al., 1999; Machesky and Insall, 1998). 
In turn, WASP activation depends largely upon the activity of the small G protein 
Cdc42 and can be regulated by WASP-interacting protein (WIP)(Abdul-Manan et al., 
1999; Calle et al., 2004; Monypenny et al., 2011; Schachtner et al., 2013; 
Vijayakumar et al., 2015). Indeed, microinjection of dominant negative Cdc42 has 
been shown to significantly impair podosome formation in human dendritic cells 
(Burns et al., 2001). Similarly, podosome formation is impaired in cells 
microinjected with dominant negative Rac1 (Burns et al., 2001), as well as in Rac1- 
and especially Rac2-depleted cells (Wheeler et al., 2006) though the downstream 
pathways are not yet elucidated. Conversely, active RhoA, which typically promotes 
assembly of stress fibres and focal adhesions, has been generally described to be 
low in podosome-forming cells (Pan et al., 2011; Yu et al., 2013) and microinjection 
of active RhoA impairs podosome formation (Burns et al., 2001).  
 
While the role of Rho family GTPases in podosome formation is relatively well-
documented, the function of ARF family of G proteins is essentially unknown. Even 
though these proteins are considered mainly as regulators of membrane traffic, 
some evidence exists that they also participate in a variety of processes related to 
regulation of the actin cytoskeleton and involved in a crosstalk with the G proteins 
of the Rho family. In particular, ARF1, the most abundant ARF family member, 
known to recruit the coatomer complexes for vesicle budding in the Golgi 
(Donaldson and Jackson 2011), was shown to be required for clathrin-independent 
endocytosis (CLIC-GEEC)(Kumari and Mayor, 2008), as well as for formation of 
“ventral actin structures” in some cell types (Caviston et al., 2014). Thus ARF1 is a 
potentially interesting candidate for function as a podosome regulator since it could 
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control fundamental systems involved in podosome formation, actin cytoskeleton 
and the plasma membrane. 
 
In this study, we demonstrate that regardless of particular stimuli, ARF1 is required 
for inducing podosome formation in different cell types. Moreover, these stimuli, via 
an ARF exchange factor ARNO, increase the fraction of GTP-bound ARF1 in cells. 
ARNO localizes to the adhesive ring of podosomes, and its inhibition interferes with 
podosome assembly. We demonstrate that the ARNO-ARF1 pathway regulates 
podosomes by inhibition of RhoA- and ROCK-dependent formation of myosin-II 
filaments, which antagonizes podosome integrity. In addition, constitutively active 
ARF1 induces formation of actin-rich puncta co-localizing with matrix degradation 
sites and containing podosome core markers. Our data strongly suggest a direct role 
for ARF1 in podosome-type adhesions, and further extends the increasing number 
of roles for ARF1 at the plasma membrane.  
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Results 
 
Depletion of endogenous ARF1 interferes with podosome formation 
 
Stimulation by either transforming growth factor-beta 1 (TGF1) or the protein 
kinase C activator, phorbol ester 12-myristate 13-acetate (PMA), has been 
previously used as a model system to study podosome formation and dynamics in 
several cell types (Burger et al., 2011; Monypenny et al., 2011; Tatin et al., 2006; 
Varon et al., 2006). Consistent with numerous previous studies, we define 
podosomes as F-actin-rich spots with a diameter of about 0.5 m surrounded by an 
approximately ring-shaped vinculin-rich zone. We consider a cell as “podosome-
forming” if it had more than 10 morphologically identifiable podosomes.  
 
In this study, 85 ± 4.7% (mean ± SD, n =3 independent experiments) of cells of the 
human monocytic cell line, THP1, plated on fibronectin-coated substrata in the 
presence of TGF1, formed podosomes after 24 hours, with 55 ± 3.2 (mean ± SEM, 
n=212 cells) podosomes per cell. The corresponding numbers for PMA-stimulated 
cells were 88 ± 5.5% and 140 ± 19.5 (n=80 cells), respectively. For cells plated on 
fibronectin in the absence of any additional stimuli, the percentage of podosome-
forming cells was only 15 ± 4.7% (n =3 independent experiments) and even among 
these cells the average number of podosomes did not exceed 22± 8.7 (n= 58 cells).  
 
To investigate the role of ARF1 in podosome dynamics, we depleted ARF1 in TGF1-
treated THP1 cells by siRNA. Immediately prior to plating, cells were electroporated 
with the ARF1 or control siRNAs and then seeded onto fibronectin in the presence of 
TGF1. We observed that maximum silencing (>95%) was achieved by 48 hours 
(Figure 1A). 
 
Depletion of ARF1 led to dramatic decrease of podosome number in TGF1-treated 
cells (Figure 1B,C). Both the number of podosomes per cell and percentage of 
podosome-forming cells significantly dropped upon ARF1 depletion (Figure 1D-F). 
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Whilst the mean number of podosomes per cell and percentage of podosome-
forming cells in cells transfected with control siRNA did not differ from 
aforementioned control numbers, the cells transfected with ARF1 siRNA had on 
average only 8 ± 1.7 (n= 96 cells) podosomes per cell. Total intensity of F-actin-
containing non-podosomal structures at the ventral surface of the cells became 
somewhat higher in ARF1-depleted cells (Figure 1B and C, left panels). At the same 
time, the vinculin-containing non-podosomal structures at the cell periphery that 
can be classified as small focal adhesions were not apparently affected (Figure 1B 
and C, right panels). Depletion of ARF1 by siRNA did not affect the integrity of the 
Golgi apparatus as visualized by cis-Golgi markers GM130/GRASP65 (Figure 1B and 
C) in agreement with previous publications (Nakai et al., 2013; Szul et al., 2007; 
Volpicelli-Daley et al., 2005).  
 
The effect of ARF1 siRNA on podosome number was specific since it could be fully 
reversed by expression of exogenous bovine HA-ARF1 insensitive to human ARF1 
siRNA (Figure 1D-F). Interestingly, exogenous HA-ARF1 was often localized in the 
spots adjacent to the podosomes of transfected cells (Figure 1D’). See below for a 
detailed analysis of localization dynamics. Significantly, we found that loss of 
podosome induction due to ARF1 depletion was not exclusive to TGF1 stimulation, 
since after PMA stimulation (Supplementary Figure S1A-I), ARF1 depleted cells 
demonstrated a significant decrease in both the number of podosomes and the 
percentage of podosome-forming cells as compared to control cells (Supplementary 
Figure S1A, D, F, G).  
 
In contrast to ARF1, depletion of ARF6 by siRNA with a silencing efficiency of >95% 
(Supplementary Figure S1J) did not affect podosome induction in TGF1-treated 
THP1 cells (Supplementary Figure S2K). Both the average number of podosomes 
per cell and the percentage of cells forming more than 10 podosomes were not 
significantly different from control siRNA-treated cells (Figure 1E and 1F). Taken 
 8 
together, these data indicate a specific role for ARF1 in podosome induction in 
stimulated THP1 cells.  
 
We also examined the effect of expression of dominant negative and constitutively 
active mutants of ARF1 on adhesion of THP1 cells in the presence of TGF1. The 
dominant negative mutant, CFP-ARF1 (T31N), led to a significant decrease of cell 
adhesion to fibronectin under these conditions (control: 71 ± 5.5%, ARF1 T31N: 4 ± 
0.3%) and the few adherent cells observed did not form podosomes (data not 
shown).  This behaviour resembles a “non-adhesive phenotype”, described 
previously in the culture of normal human dendritic cells (Burns et al., 2004). 
Unexpectedly, the expression of a constitutively active mutant of ARF1, CFP-ARF1 
(Q71L), also interfered with cell adhesion and completely prevented podosome 
formation.  Thus, sustained high activity of ARF1 is also damaging for cell adhesion 
and podosome formation in THP1 cells.  Overexpression of wild-type ARF1 or 
constitutively active ARF1 in unstimulated THP1 cells did not induce any apparent 
phenotypic changes. These cells remain poorly attached to the fibronectin and do 
not form podosomes.  
 
ARF1-containing vesicles transiently contact podosomes  
 
We used fluorescently-tagged ARF1 to further elucidate the localization and 
dynamics of ARF1 in TGF1-stimulated THP-1 cells. Expression of GFP-ARF1 
showed a predominant Golgi localization (Figure 1D) in agreement with previous 
publications (Lippincott-Schwartz et al., 1989; Sciaky et al., 1997). However, in 
addition to the Golgi localization, we found numerous irregular puncta throughout 
the cell, some of which were apparently associated with podosomes (Figure 1D’ and 
Figure 2A).  
 
We employed total internal reflection fluorescence (TIRF) microscopy to explore the 
spatiotemporal dynamics of ARF1 puncta at the plasma membrane. GFP-ARF1 
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puncta displayed temporal localization at regions of podosome assemblies and 
made transient periodic contacts with the adhesive rings of podosomes, as marked 
by mCherry-vinculin in THP1 cells (Figure 2B, 2B’ and Supplementary movie 1). Up 
to 80% of podosomes appeared to be in contact with ARF1-containing puncta 
during 5-minute periods of observation (Figure 2C) with an average dwell time of 
10 ± 1.6 seconds (mean ± SEM, Figure 2D). In contrast, CFP-ARF6 does not form 
puncta-like structures in THP1 cells and no preferential localization of CFP-ARF6 to 
regions of podosome assembly was found (Supplementary Figure S1L). We further 
characterized the GFP-ARF1 associated puncta by determining if their mobility was 
dependent on a cytoskeletal network. We found that GFP-ARF1 patches appeared to 
be travelling on microtubule tracks identified by labeling with mCherry-ensconsin 
(Figure 2E,F and Supplementary movie 2). To elucidate the nature of the ARF1 
puncta, we co-express GFP-ARF1 with several markers of vesicular traffic carriers, 
Rab6, Rab7, Rab8 and Rab11 (Supplementary Figure S2A-D). Amongst those, Rab11 
(Welz et al., 2014) demonstrated significant co-localization (Supplementary Figure 
S2E) with ARF1 suggesting that ARF1-containing puncta have a vesicular nature.  
 
Inhibition of ARF1 activity interferes with formation of podosomes induced by 
diverse stimuli 
 
 
To study the immediate effect of ARF1 inhibition on podosome formation, we used 
two inhibitors known to suppress ARF1 activity. Brefeldin A (BFA) promotes 
formation of complexes between GDP-bound ARF1 and Sec7 domains of ARF1 
nucleotide exchange factors GBF1, BIG1 and BIG2, and prevents completion of the 
nucleotide exchange reaction (D'Souza-Schorey and Chavrier, 2006), while secinH3 
inhibits activity of another group of ARF exchange factors, cytohesins (1-4), by 
binding to their Sec7 domain, without formation of a complex with ARF1 (Casanova, 
2007).  
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Using a G-LISA assay for the measurement of ARF1-GTP levels, we demonstrate that 
TGF1 or PMA treatment of THP1 cells enhances the fraction of active, GTP-bound 
ARF1, while both secinH3 and BFA significantly reduced it (Figure 3A, 
Supplementary Figure S1C). Both secinH3 and BFA treatment induced rapid 
disassembly of all podosomes in about 30-40 minutes (Figure 3B-D, graphs 3E, F 
and Supplementary movie 3). In the case of secinH3, this process was accompanied 
by a burst of lamellipodial activity (Figure 3B), the integrity of the Golgi apparatus, 
as well as localization of ARF1 to Golgi and to vesicular structures in the cytoplasm 
was not affected (Figure 3B, 3C).  Unlike secinH3 treatment, disruption of 
podosomes with BFA was accompanied by loss of ARF1 localization at the Golgi and 
at cytoplasmic vesicular structures (Figure 3D) as well as structural disintegration 
of the Golgi apparatus, in agreement with numerous previous studies (Donaldson et 
al., 2005; Lippincott-Schwartz et al., 1989).  Thus, comparison between the SecinH3 
and BFA effects confirmed that active ARF1 is required for podosome integrity and 
this function of ARF1 does not depend on its role in Golgi stabilization.  A second 
confirmation of independence of podosomes from Golgi traffic can be inferred from 
experiments with knockdown of COPB1, a subunit of the COPI coatomer protein 
complex required for retrograde transport from trans-Golgi to cis-Golgi and 
endoplasmic reticulum (Beck et al., 2009). We found that COPB1 knockdown or its 
inhibition generated only minor effects on podosome integrity (Supplementary 
Figure S3A-E).  Finally, disruption of podosomes with secinH3 or BFA still 
proceeded (albeit in a slower rate) in TGF1-stimulated THP1 cells expressing 
constitutively active Cdc42 (GFP-Cdc42 Q61L), a potent podosome-inducing 
signalling protein (Supplementary Figure S3H). Moreover, treatment of cells with 
BFA or SecinH3 as well as knockdown of ARNO or ARF1 did not change the level of 
Cdc42-GTP in TGF-stimulated THP1 cells (Supplementary Figure S3I and J).   
 
Visualization of podosomes using structured-illumination microscopy (SIM) 
revealed a central F-actin core surrounded by patches enriched in adhesion proteins 
(talin and vinculin) as well as the thin F-actin-rich links connecting neighboring 
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podosomes (Supplementary Figure S4A, boxed image S4A’ and Supplementary 
movie 4) in agreement with previous studies (Cox et al., 2012; Dries et al., 2013). 
Treatment with secinH3 led to the rapid disappearance of the connecting links and 
gradual concurrent disassembly of both the actin cores and surrounding adhesive 
rings (Supplementary Figure S4B, C and Supplementary movie 5).  
 
In view of the high podosome turnover rate (Dries et al., 2013), gradual disruption 
of podosomes upon addition of secinH3 suggests that inactivation of ARF1 changes 
the balance between podosome assembly and disassembly rather than completely 
block the assembly processes. The process of disassembly often proceeds through 
podosome fission and is accompanied by an apparent increase of podosome 
mobility in the plane of the plasma membrane (Supplementary Figure S4D-F).  
 
We next studied the effect of inhibition of ARF1 on podosome-like structures 
formed by fibroblast-type cells. Under standard culture conditions, mouse 
embryonic fibroblasts (MEFs) generally form focal adhesions, which appeared to be 
resistant to treatment with either BFA (Bershadsky and Futerman, 1994) or 
SecinH3 (Supplementary Figure S5A). It was recently shown that fibroblasts plated 
on a fluid substratum (supported RGD-functionalized lipid bilayer), under 
conditions where they cannot exert traction forces, by default formed podosome-
like adhesion structures (Yu et al., 2013). We showed that the level of GTP-ARF1 
increased in MEF plated on supported lipid bilayers (Figure 3G). Similarly to 
“classic” podosomes, podosome-like structures formed by MEFs plated on the lipid 
bilayer underwent rapid disassembly upon treatment with either BFA or SecinH3 
(Figure 3H, I).  
 
A well-known method of induction of podosome-like structures in fibroblast-like 
cells is ectopic expression of constitutively active Src. In agreement with published 
results (Tarone et al., 1985), expression of Src Y527F in MEFs led to the formation of 
prominent rosettes formed as a result of fusion of numerous podosome-like 
structures (Supplementary Figure S5B and C). Treatment of such cells with either 
 12 
BFA or SecinH3 resulted in the gradual disassembly of these rosettes and a decrease 
in the number of rosette-positive cells (Supplementary Figure S5B and C). 
 
Altogether, these data demonstrate that ARF1 activity is required for 
formation/maintenance of podosome-like structure irrespective of upstream stimuli 
(TGF1, PMA, active Src or fluid substratum).   We conclude that a role for ARF1 in 
podosome dynamics is independent of early signalling pathways that lead to 
initiation of cellular differentiation to a podosome-generating phenotype. 
 
ARNO GEF activates ARF1 to drive podosome formation 
 
The mammalian ARF GTPases are activated by 15 different GEFs categorized in five 
classes. Among these, only 7 GEFs can activate ARF1: 3 BFA-sensitive (GBF1, BIG1, 
BIG2) and 4 SecinH3-sensitive (cytohesins 1-4) (D'Souza-Schorey and Chavrier, 
2006; Donaldson and Jackson, 2011). Both BFA- and SecinH3-sensitive GEFs share a 
common conserved SEC7 domain that promotes GDP release and subsequent GTP 
binding to ARF1. SecinH3-sensitive GEFs have in addition a pleckstrin homology 
(PH) domain that enables them to interact with phosphoinositides at the plasma 
membrane (DiNitto et al., 2007; Santy et al., 1999). 
 
We examined the effect of inhibition of a number of ARF1 GEFs on the process of 
podosome formation (Supplementary Figure S3B, D-G). We found that expression of 
dominant negative mutants of two BFA-sensitive GEFs, HA-BIG1 (E793K) and HA-
BIG2 (E738K) did not prevent formation of podosomes in THP1 cells treated with 
TGF1 (Supplementary Figure S3F and G, lower panel). Conversely podosomes 
formation was not affected by overexpression of wild-type HA-BIG1 or HA-BIG2 
(Supplementary Figure S3F and G, upper panel). Furthermore, both the wild-type 
HA-BIG1 and HA-BIG2 showed predominant Golgi localization (Supplementary 
Figure S3F and G) and no podosome localization, consistent with previous reports 
(Citterio et al., 2006; Ishizaki et al., 2008). To inhibit the activity of the third BFA-
sensitive GEF, GBF1, we used a small-molecule inhibitor, Golgicide A (Saenz et al., 
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2009). We found only partial dissolution of podosomes in THP1 cells treated with 
TGF1 after application of Golgicide A in a concentration that induced visible 
fragmentation of the Golgi complex (Supplementary Figure S3B, D and E).  Thus, in 
spite of profound inhibitory effect of BFA on podosome formation, selective 
inhibition of the BFA-sensitive GEFs produced only minor effect on podosomes.  
 
In contrast, knockdown of one of the SecinH3-sensitive GEFs, ARNO (cytohesin-2), 
significantly affected podosome formation in TGF1- (Figure 4A-D) or PMA- 
activated THP1 cells (Supplementary Figure S1B, E, H, I). Knockdown of ARNO led to 
a significant decrease in the number of podosomes per cell as well as the percentage 
of cells having more than 10 podosomes (Figure 4C and 4D). Additionally we found 
that ARNO knockdown reduced ARF1 activity in THP1 cells stimulated by TGF1 
(Figure 4E). Moreover, a dominant negative mutant of ARNO (E156K) also 
suppressed podosome formation/maintenance (Figure 4F and 4G). The effect of 
ARNO knockdown on podosomes was specific since knockdown of another secinH3-
sensitive GEF, cytohesin-1 did not inhibit podosome formation in stimulated THP1 
cells (Figure 4B). Neither ARNO nor cytohesin-1 knockdown produced any 
significant effect on Golgi integrity (Figure 4B).  
 
Next, we investigated the localization of ARNO and cytohesin-1 in TGF1-treated 
THP1 cells by expressing GFP-fusion construct of these GEFs. ARNO was found to 
localize to the rings surrounding the actin cores of podosomes (Figure 5A). 
Similarly, GFP-ARNO localized to the rim around the actin core of podosome 
rosettes (Figure 5B). Moreover, podosome-like structures formed by normal 
fibroblasts plated on RGD-functionalized lipid bilayers also contain ARNO in the 
rings surrounding the actin cores (Figure 5C). Live imaging of GFP-ARNO in all these 
situations revealed that ARNO localization at the podosome ring was stable and 
spanned the entire lifetime of a podosome (Figure 5D,D’ and Supplementary movie 
6). Unlike ARNO, Cytohesin-1 showed diffuse localization over the plasma 
membrane and was not enriched at podosomes (Figure 5E).  
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Inhibition of ARF1 triggers podosome disassembly via activation of Rho and 
myosin-IIA  
 
In search of downstream factors that mediate podosome disruption upon ARF1 
inhibition we checked the activity of three major Rho family G proteins in TGF1-
treated THP1 cells. We found that the fraction of RhoA-GTP significantly increased 
upon inhibition of ARF1 by SecinH3 (Figure 6A), while activities of both Rac1 and 
Cdc42 did not change (Figure 6B and C). RhoA and Rho-associated kinase (ROCK) 
are master regulators of myosin-IIA-driven cell contractility, since ROCK-mediated 
activation of myosin regulatory light chain (MRLC) phosphorylation promotes 
assembly of myosin-II filaments as well as myosin-II motor activity (Vicente-
Manzanares et al., 2009). Indeed, we have demonstrated that inhibition of ARF1 by 
SecinH3 promoted assembly of the myosin-II filaments visualized by live imaging of 
GFP-MRLC using SIM (Figure 6D and Supplementary movie 7). Simultaneous 
visualization of podosomes and myosin-II filaments revealed that podosome 
disappearance occurred in those cell regions enriched in myosin-II filaments (Figure 
6D), suggesting that podosome disassembly is triggered by local activation of 
myosin-II-driven contractility. Indeed, treatment of ARF1-inhibited cells lacking a 
majority of podosomes with an inhibitor of ROCK, Y-27632, led to a burst of 
podosome formation concurrent with the disappearance of myosin-II filaments 
(Figure 6E and Supplementary movie 8). To confirm that inhibition of ARF1 led to 
podosome disruption via activation of myosin-II filament assembly, we performed 
siRNA-mediated myosin-IIA heavy chain (MYH9) knockdown, which completely 
blocked formation of myosin-IIA filaments as visualized by antibody to NM-MHCIIA 
(Figure 6F-H). Myosin-II knockdown by itself did not affect podosome integrity 
(Figure 6F, I, K and L). While treatment of THP1 cells transfected with control siRNA 
by SecinH3 led to pronounced disassembly of podosomes (Figure 6G, K and L), the 
same treatment on myosin-IIA knockdown cells did not disrupt podosomes (Figure 
6J, K and L).    
   
 15 
Constitutively active ARF1 induces actin-rich puncta in fibroblasts 
 
 To test if constitutively active ARF1 could induce formation of podosome-like 
adhesions in a more general context, we expressed constitutively active ARF1, CFP-
ARF1 (Q71L), in cells that normally do not form podosomes, such as mouse 
embryonic fibroblasts (MEFs). Overexpression of constitutively active but not wild 
type ARF1 induced formation of numerous actin-rich puncta localized to the ventral 
surface of these cells, in the same focal plane as focal adhesions (Figure 7A and B). 
Similar to mature podosomes, the actin-rich puncta induced by constitutively active 
ARF1 (CFP-ARF1 Q71L) were transiently associated with CFP-ARF1 (Q71L)-
containing vesicles (Figure 7B’). Formation of these puncta was accompanied by 
some reduction in the number of stress fibres and focal adhesions, but even total 
disassembly of these structures upon expression of dominant negative RhoA (GFP-
RhoA T19N) was not sufficient to induce actin-containing puncta (Figure 7C). At the 
same time, constitutively active ARF1 efficiently triggered formation of such puncta 
in cells also expressing dominant negative RhoA (Figure 7D). Similarly, inhibition of 
Rho activity by cell-permeable C3 transferase (2 g/ml) did not by itself induce 
formation of the actin puncta and did not interfere with the induction of these 
puncta by constitutively active ARF1 (Supplementary Figure S5D and E). 
 
Proteins typically associated with podosome cores in different cell types (WIP, N-
WASP, cortactin, Arp3, dynamin-2) were found in the actin-rich puncta 
(Supplementary Figure S5F-J). At the same time, protein components of the 
podosome “ring”, such as vinculin (not shown) and paxillin (Supplementary Figure 
S5K), were not found to be associated with active ARF1-induced actin puncta 
suggesting incomplete podosome formation. ARF1-induced actin puncta were not 
related to clathrin-depended endocytic activity since they did not co-localize with 
clathrin-coated pits (Supplementary Figure S5L).  
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Unlike native podosomes, the puncta induced by constitutively active ARF1 were 
motile. While podosomes of THP1 cells (Supplementary Figure S4D, right insets), as 
well as podosome-like structures in fibroblasts plated on fluid substrate (Yu et al., 
2013), are essentially stationary with respect to the substratum, the positions of 
puncta induced by active ARF1 are oscillating with an average velocity of 0.88 ± 0.28 
m/s (± SD). Thus constitutively active ARF1 induced formation of actin-rich puncta 
in proximity to the ventral cell membrane that can be considered as incompletely 
anchored podosome-like structures and possibly podosome precursors. 
 
In spite of the difference between authentic podosomes and the actin-rich puncta 
induced by constitutively active ARF1, the puncta mimic one important podosome 
function namely, matrix metalloproteinase (MMP)-dependent ability to degrade the 
matrix. Indeed, the positions of actin puncta induced in the fibroblasts by 
constitutively active ARF1 (Q71L) coincided with the sites of matrix degradation - 
dark areas on the substratum covered with fluorescently-labeled gelatin (Figure 7G, 
G’). Formation of such dark areas could be prevented by treatment with 25 M of 
MMP inhibitor GM6001 (Figure 7H,H’), and therefore depended on the exocytosis of 
MMPs by cells. Thus, our experiments showed that actin puncta induced in 
fibroblasts by constitutively active ARF1 trigger local matrix degradation by 
facilitating exocytosis of MMPs independent of podosome ring assembly.  
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Discussion 
 
In this paper we demonstrate that an ARNO-ARF1 signalling axis is required for the 
maintenance of podosome integrity (See Figure 8 for flow diagram). First, 
knockdown of ARF1 but not ARF6 prevents podosome formation by TGF1- or 
PMA-treated THP1 cells. In addition to these “classic” podosomes, we explored 
podosome-like structures induced in fibroblasts by either expression of 
constitutively active Src (Tarone et al., 1985) or by plating cells on a fluid 
substratum (Yu et al., 2013). We checked that specific drugs inhibiting ARF1-
activating GEFs, BFA (Niu et al., 2005; Yamaji et al., 2000) and secinH3 (Hafner et al., 
2006), led to rapid dissolution of podosomes in THP1 cells and the podosome-like 
structures in fibroblasts. In addition, we have shown that in both THP1 cells and 
fibroblasts, treatments inducing podosome formation augmented the fraction of 
active, GTP-bound ARF1. 
 
BFA and secinH3 inhibit different classes of ARF1-activating GEFs (Donaldson and 
Jackson, 2011). In our experiments, the BFA-sensitive GEFs (GBF1, BIG1, BIG2) 
appeared to be functionally unrelated to podosome regulation. The inhibitory effect 
of BFA could thus be explained by sequestration of ARF1 within the BFA-induced 
ternary complexes consisting of inhibited GEFs, ARF1-GDP and BFA (Mossessova et 
al., 2003; Peyroche et al., 1999; Zeghouf et al., 2005). At the same time, we found 
that one of the secinH3-sensitive GEFs, ARNO (cytohesin-2) but not cytohesin-1, is 
indispensable for podosome integrity in THP1 cells. Possible functions of several 
other ubiquitous ARF family proteins (ARF3, ARF4, ARF5) as well as other secinH3-
sensitive GEFs, cytohesin-3 and -4, remained to be studied in the context of 
podosome formation.  
 
Localization studies revealed that ARNO (but not cytohesin-1) is stably co-localized 
with adhesion proteins in the ring domain of podosomes in THP1 cells as well as 
with podosome-like structures in fibroblasts. This is consistent with biochemical 
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data showing direct association of ARNO with paxillin (Torii et al., 2010). 
Furthermore, live cell imaging showed transient contacts of vesicles containing 
ARF1 with the periphery and ring domain of podosomes and podosome-like 
structures in THP1 cells. We demonstrated that ARF1-containing vesicles are 
moving along microtubules; so one of the functions of microtubules important for 
the podosome maintenance (Linder et al., 2000) could be delivery of ARF1. It is 
worth noting that a negative regulator of ARF1 activity, ARF1 GTPase-activating 
protein ASAP1, was also shown to localize to podosomes (Curtis et al., 2015; Shiba 
and Randazzo, 2011).  
 
How could active ARF1 affect podosome assembly and stability? The first possibility 
is based on well-documented functions of ARF1 in the Golgi complex and vesicular 
traffic (Donaldson et al., 2005). It can be conjectured that some of the ARF1-
dependent functions of the Golgi are required for podosome integrity. This 
possibility cannot be entirely excluded; however, it is worth noting that in our 
experiments integrity of podosomes can be dissected from the integrity of the Golgi. 
In particular, inhibition of the ARF1 exchange factor GBF1, responsible for ARF1-
dependent COPI recruitment to the Golgi, as well as knockdown of the COPI subunit, 
COP, only marginally affected podosome integrity. ARF1 in principle could be 
involved in integrin turnover and affect podosome formation via regulation of 
available integrin adhesion receptors. However, in our experiment, experimental 
manipulations with ARF1 did not affect the integrity or dynamics of another class of 
integrin-dependent adhesions, focal adhesions. This suggests that other 
mechanisms should be considered to explain the specific effect of ARF1 
depletion/inhibition on podosome integrity. 
 
Podosomes are part of the actin cytoskeleton and as such likely to be regulated by 
small G proteins of Rho family. We have shown that inhibition of ARF1 triggered 
significant activation of RhoA but not Rac or Cdc42. Activation of RhoA in turn 
triggers the assembly of numerous myosin-IIA filaments, which as we have 
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demonstrated led to considerable disruption of podosomes. We have shown that 
suppression of myosin-IIA filament formation by either inhibition of ROCK or 
knockdown of myosin-IIA, prevented the disruptive effect of ARF1 inhibition on 
podosome formation.  Thus, our experiments suggest that ARF1 functions in 
podosome formation as an inhibitor of RhoA activity and subsequent myosin-IIA 
filament formation. This conclusion is consistent with our observation that ARF1-
dependent activation of podosome formation by plating of cells on fluid bilayer led 
to inhibition of RhoA (Yu et al., 2013).  
 
Interestingly, apparently the same mechanism based on suppression of Rho and 
myosin-II by the cytohesin family exchange factor, Steppke, and a Drosophila ARF 
was found in a completely different system, during cellularization of Drosophila 
embryos (Lee and Harris 2013). However, the pathway connecting ARF1 and RhoA 
remains unknown. It is perhaps worth noting that ARF1 can bind the RhoGAP 
ARHGAP10/21 and deliver it to the Golgi or plasma membrane (Dubois et al., 2005; 
Kumari and Mayor, 2008; Menetrey et al., 2007). ARHGAP10/21 is known to inhibit 
Cdc42 but also shows some RhoA inhibitory activity in vitro (Dubois et al., 2005).  
 
It is also not clear why an excess of myosin-II filaments antagonizes podosome 
integrity. Myosin-II has been shown to localize to actin links radiating from the 
podosomes (Dries et al., 2013) but its functional role in podosomes is yet to be 
established.  
 
In addition to its function as a myosin-II regulator, ARF1 could affect podosomes via 
regulation of actin polymerization. There are several lines of evidence suggesting 
involvement of ARF1 in the regulation of Arp2/3 complex-driven actin 
polymerization: via recruitment of actin nucleation promoting WAVE complex 
(Humphreys et al., 2012a; Humphreys et al., 2012b), via sequestration and 
inactivation of Arp2/3 inhibitor, PICK1 (Rocca et al., 2013) and via activation of 
Cdc42 (Dubois et al., 2005; Heuvingh et al., 2007). We were not able to find evidence 
of any of these mechanisms in the context of podosome regulation. Neither data 
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from the literature nor our own observations indicate that WAVE or PICK1 are 
localized to podosomes.  Moreover, ARF1 inhibition did not induce any changes in 
GTP-bound Cdc42 level, and constitutively active Cdc42 did not prevent or 
overcome the disruption of podosomes seen upon ARF1 inhibition.    
 
Nevertheless, the effect of ARF1 on the polymerization of actin in the context of 
podosome formation is seen in our experiments with expression of constitutively 
active ARF1 in fibroblast-type cells, which normally do not produce podosomes. 
Active ARF1 not only suppresses stress fibre formation but also induces formation 
of numerous actin and Arp3-containing patches in such cells. The induction of actin 
polymerization at the plasma membrane by active ARF1 and ARF6 was previously 
demonstrated (Caviston et al., 2014). Many actin-associated proteins typical of 
podosomes (N-WASP, WIP, cortactin, dynamin-II) were also found in these puncta. 
Moreover, a hallmark of podosome function, the local gelatin matrix degradation by 
MMPs appeared to be associated with these puncta. At the same time, the puncta 
were not surrounded by any podosome adhesive ring components. The recruitment 
of certain adhesion components such as paxillin was shown to require dynamic 
GTP/GDP turnover of ARF1(Liu et al., 2002; Liu et al., 2005). This may explain the 
lack of adhesive ring surrounding podosome core-like structures induced by 
constitutively active ARF1. Of note, our data show that matrix degrading and 
adhesion functions could be dissected under conditions of induction of podosome 
precursors by constitutively active ARF1.  
 
The pathways downstream of ARF1 underlying formation of these podosome 
precursors are not the same as Rho and myosin-II inhibitory activity of ARNO-ARF1 
characterized above, since expression of dominant negative RhoA did not by itself 
induce formation of the actin-rich puncta in fibroblasts. We cannot exclude that local 
changes in Cdc42 activity may still play a role in this process (Heuvingh et al., 2007) 
even though ARF1 did not affect the total level of Cdc42 activity in our experiments.   
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In summary, we demonstrate that the signalling axis ARNO-ARF1 plays a critical 
role in the control of podosome integrity and find that this pathway in macrophage-
like cells operates via inhibition of RhoA and myosin-II activity. Other pathway(s) 
found in fibroblasts downstream of active ARF1 induce formation of F-actin-rich 
puncta resembling podosome actin cores that are not associated with the matrix 
adhesion components but involved in matrix degradation. These findings open new 
features of the processes of podosome formation and matrix degradation. 
Investigation of ARNO-ARF1 upstream and downstream pathways provides a rich 
source of future studies.    
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Materials and Method 
 
Cell culture and transfection procedures  
THP1 human monocytic leukemia cell line was obtained from Health Protection 
Agency Culture Collections (Porton Down, Salisbury, UK) and cultured using 
Roswell Park Memorial Institute (RPMI-1640) supplemented with 10% HI-FBS and 
50 g/ml 2-Mercaptoethanol (Sigma-Aldrich) at 37C and 5% CO2.  
 
The suspended THP-1 cells were differentiated into adherent macrophage-like cells 
either with 1 ng/ml human recombinant cytokine TGF1 (R&D Systems) or 50 nM 
Phorbol 12-myristate 13-acetate (Sigma-Aldrich) for 24 or 48 hours on fibronectin-
coated glass substrates. No apparent difference between the phenotype of cells 
stimulated for 24 or 48 hours were detected. 35-mm ibidi (Cat. 81158) glass-
bottomed dishes were coated with 1 g/ml of fibronectin (Calbiochem, Merck 
Millipore) in phosphate buffered saline (PBS) for 1-2 hours at 37C, washed with 
PBS twice, and incubated in complete medium prior to seeding of cells.     
Cells were transiently transfected prior to stimulation with DNA plasmids using 
electroporation (Neon Transfection System, Life Technologies) in accordance to 
manufacturer’s instructions. Specifically, two pulses of 1400V for 20 milliseconds 
were used. 
 
For siRNA transfection, THP1 cells were treated with 100nM of ARF1 siRNA 
(Dharmacon, ON-TARGETplus SMARTpool siRNA, catalogue no. L-011580-00-0005), 
150nM of ARF6 siRNA (Dharmacon, ON-TARGETplus SMARTpool siRNA, catalogue 
no. L-004008-00-0005), 100nM of MYH9 siRNA (Dharmacon, ON-TARGETplus 
SMARTpool siRNA catalogue no. L-007668-00-0005) or 100nM of COPB1 siRNA 
(Dharmacon, ON-TARGETplus SMARTpool siRNA, catalogue no. L-017940-00-0005). 
For control experiments, cells were transfected with  (Dharmacon, ON-TARGETplus 
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Non-targeting pool siRNA, catalogue no. D-001810-10) at a concentration similar to 
individual gene-targeted siRNAs.  
 
For knockdown of ARF GEFs in THP1 cells, siRNA duplex 
‘GCAAUGGGCAGGAAGAAGU’ (Oh et al 2010) against human ARNO sequence and 
‘AUGGAGGAGGACGACAGCUAC’ (Sendide et al 2005) against human cytohesin-1 with 
dT-dT overhangs were purchased from Sigma-Aldrich. For rescue experiments in 
Figure 1D, ARF1 siRNA transfected THP1 cells were co-transfected with HA-ARF1 
(bovine origin, non-sensitive to aforementioned ARF1 siRNA) and fixed 48 hours 
after plating on fibronectin.   
 
Immortalized rptp-(+/+) mouse embryonic fibroblasts (Su et al 1999) that was 
termed MEFs, were obtained from the Sheetz laboratory (Mechanobiology Institute, 
Singapore). MEFs were cultured in Dulbecco’s modified Eagle’s Medium high 
glucose (DMEM), supplemented with 10% heat-inactivated fetal bovine serum (HI-
FBS, Gibco), 1% L-Glutamine, and 100 IU/mg penicillin-streptomycin (Invitrogen) 
at 37C and 5% CO2. MEFs were transiently electroporated with a single pulse of 
1400V for 20 milliseconds. MEFs were either seeded on fibronectin-coated 35-mm 
ibidi or 27-mm IWAKI (Japan) glass-bottomed dishes for 24 hours post-
transfection. For plating on supported lipid bilayer membrane, transfected MEFs 
were seeded on 6-well Nunc (Thermo Fisher Scientific) plastic dishes for 24 hours 
post-transfection. These MEFs were then treated with trypsin solution, TrypLE™ 
(ThermoFisher Scientific), for 5 mins and kept in suspension for 15 minutes in 
complete medium to recover from trypsinization prior to seeding on supported 
lipid bilayer membrane.    
 
Plasmids 
mCherry-WIP and GFP-WASP were described in (Vijayakumar et al 2015); GFP--
actin and mCherry-Talin – in (Cox et al 2012).  The following plasmids described in 
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corresponding references were kindly provided by the following researchers. 
EGFP-ARNO (Santy et al 1999) and EGFP-ARNO E156K (Hernández-Deviez et al 
2003) – by Dr James Casanova (University of Virginia, VA, USA); EGFP-Cytohesin-1 
(Bourgoin et al 2002) – by Dr Sylvain Bourgoin (CHU de Québec Research Center, 
University of Laval, Quebec, Canada); ARF1-RFP (Hsu et al 2010) – by Dr Nihal 
Altan-Bonnet (NIH, Bethesda, MD, USA); GFP-Vinculin (Zamir et al 1999) and 
mCherry-Vinculin – by Dr Michael Davidson (Florida State University, FL, USA); 
GFP-Paxillin and mApple-Paxillin (Kanchanawong et al 2010) – by Dr Pakorn 
Kanchanawong (Mechanobiology Institute, Singapore); constitutively active Src 
Y527F – by Dr Keiko Kawauchi (Mechanobiology Institute, Singapore); EGFP-
Rab6A (Miserey-Lenkei S et al 2010) – by Dr Stéphanie Miserey Lenkei (Institute of 
Curie, Paris, France); GFP-Mannosidase II (Galen J et al 2014) – by Dr Vivek 
Malhotra (Center of Genomic Regulation, Barcelona, Spain); mApple-Rab11A 
(verified in-house) – by Dr Vicki Allan (University of Manchester, UK); GFP-
Dynamin II (Ochoa et al 2000) – by Dr Pietro De Camilli (Yale University, USA); 
Myosin regulatory light chain-GFP – by Dr Mark Dodding (King’s College London, 
UK). All BIG constructs (HA-BIG1, HA-BIG2, HA-BIG1 E793K, HA-BIG2 E738K 
(Ishizaki et al 2008) – by Dr Hye-won Shin (Kyoto University, Kyoto, Japan). 
The following plasmids described in corresponding references were purchased 
from Addgene (Cambridge, MA, USA): ARF1-GFP (Chun et al 2008, Addgene 
#39554), ARF1-ECFP (Beemiller et al 2006, Addgene #11381), ARF1(T31N)-ECFP 
(Beemiller et al 2006, Addgene #11384), ARF1(Q71L)-ECFP (Beemiller et al 2006, 
Addgene #11385), HA-ARF1 (Furman et al 2002, Addgene #10830), GFP-Rab11 
(Choudhury et al 2002, Addgene #12674), mCherry UtrCH (Burkel et al 2007, 
Addgene #26740), EMTB-mCherry (Miller et al 2009, Addgene #26742), GFP-RhoA 
(T19N) (Subauste et al 2000, Addgene #12967), ARF6-CFP (Beemiller et al 2006, 
Addgene #11382), mCherry-Arp3 (Taylor et al 2011, Addgene #27682), mCherry-
Cortactin (Taylor et al 2011, Addgene #27676), mCherry-clathrin light chain 
(Taylor et al 2011, Addgene #27680), dsRed Rab7 (Choudhury et al 2002, 
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#Addgene 12661), GFP-Rab8A (Guizetti et al 2011, Addgene #31803), 
EMTB(ensconsin)-mCherry (Miller et al 2009, Addgene #26742). 
 
Supported lipid bilayer membrane 
 
Methodologies of supported lipid bilayer preparation and membrane 
functionalization have been described in Yu et al 2011 and Yu et al 2013.  Briefly, 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoyl-sn- glycero-
3-phosphoethanolamine-N-(cap biotinyl) (16:0 biotinyl-Cap-PE) were purchased 
from Avanti Polar Lipids. The lipids (0.2 mol% of biotinyl- Cap-PE and 99.8 mol% of 
DOPC) were mixed with an equal volume of PBS and then pipetted onto cleaned 
glass substratum where a 25-mm coverslip was placed over it for self-assembly of 
lipid vesicles.  The lipid-coated coverslips were immersed into a deionized water 
bath and then placed and sealed in an Attofluor cell chamber (Life Technologies). 
The supported lipid bilayer membrane ensemble was kept under aqueous 
environment at all times. For membrane functionalization, the supported lipid 
membrane was blocked with 50 g/ml of Casein. A total of 0.1 g/ml of Cascade 
blue neutravidin (Life Technologies) was added onto supported lipid membranes, 
followed by 1 g/ml of biotinylated RGD, cyclo (Arg-Gly-Asp-D-Phe-Lys [Biotin-
PEG-PEG]; Peptides International). Cells were then added onto the RGD-
functionalized lipid bilayer membrane and imaged or fixed within 2-3 hours of 
preparation.  
 
Drug treatment  
For drug inhibition studies, cells were treated with 30 M SecinH3 (Tocris), 10 M 
Golgicide A (Santa Cruz Biotechnology), 5 g/ml Brefeldin A (Sigma-Aldrich), 30 
M Y-27632 (Sigma-Aldrich), 25 M GM6001 (Enzo Life Sciences), 2 g/ml C3 
transferase (Cytoskeleton) in complete medium for 1-2 hours or 4 hours for 
GM6001 at 37C with 5% CO2 and subsequently fixed with 4% PFA. For live cell 
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imaging, cells were imaged immediately after addition of appropriate inhibitors, 
which remained in the medium during the entire period of image acquisition. To 
study effect of inhibitors on podosomes formed by MEFs plated on RGD lipid 
bilayer, the cells were treated with appropriate inhibitors 30-45 minutes following 
cell seeding on the bilayer.  
 
Immunoblotting 
 
For verification of knockdown experiments, cells were lysed in RIPA buffer 48 hours 
after transfection and extracted proteins were separated by 4-20% SDS- 
polyacrylamide gel (Thermo Fisher Scientific) and transferred to PVDF membranes 
(Bio-Rad) before incubation at 75V for 2 hours and blocked for 1 hour with 5% non-
fat milk (Bio-Rad) or bovine serum albumin (BSA, Sigma-Aldrich). The PVDF 
membranes were incubated overnight at 4C with appropriate antibodies: anti-
ARF1 (Abcam, catalogue no. ab108347, dilution 1:1000); anti-ARF6 (Abcam, 
catalogue no. ab77581, dilution 1:1000); anti-ARNO (Abcam, catalogue no. ab56510, 
dilution 1:1000); anti-cytohesin-1 (Merck Millipore, catalogue no. MABT14, dilution 
1:500); anti--tubulin (Sigma-Aldrich, catalogue no. T6199, dilution 1:3000); Anti-
COP (Abcam, catalogue no. ab2899, dilution 1:1000); anti-HA (Cell Signaling 
Technology, catalogue no. 2367, dilution 1:1000); anti-Cdc42 (Cell Signaling 
Technology, catalogue no. 2462, dilution 1:1000); anti-RhoA (Santa Cruz 
Biotechnology, Inc., catalogue no sc-418, dilution 1:1000); anti-Rac1 (BD 
Biosciences, catalogue no. 610650, dilution 1:1000); Anti-non muscle myosin-IIA 
(Sigma-Aldrich, catalogue no. M8064, dilution 1:1000).  
 
After three washes (10 minutes each), appropriate secondary antibodies conjugated 
with horseradish peroxidase (Bio-Rad) were incubated with the membrane for 1 
hour, washed three times (15 minutes at room temperature), and detected by 
Pierce™ ECL western blotting substratum (Thermo Fisher Scientific) using CL-
Xposure film (Thermo Fisher Scientific).  
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 Small G protein activity assay 
 
Total cell lysates were collected and immediately quantified by the G-LISA ARF1 or 
Cdc42 Activation Assay Biochem Kit (colorimetric-based) and performed as per 
manufacturer’s protocol (Cytoskeleton, Inc.). Samples were run in duplicates per 
sample, averaged and then normalized to the total ARF1 or Cdc42 levels detected by 
immunoblotting. For each set of experiment, data were normalized to TGF1-
treated THP1 cells giving a fold-change value from zero (minimum) to one 
(maximum). Pull-down assay using GST-tagged RhoA-binding domain of Rhotekin 
was used to precipitate GTP-bound RhoA while GST-tagged Rac1/Cdc42-binding 
domain of PAK1 (PBD) beads were used to precipitate GTP-bound Rac1 or Cdc42 in 
THP1 cells. Pulled-down RhoA, Rac1 and Cdc42 were immunoblotted using 
respective antibodies as described above.  
 
Immunofluorescence 
 
Cells were fixed with 3.7% paraformaldehyde in PBS, washed twice and 
permeabilized with 0.5% triton X-100 (Sigma-Aldrich) in PBS for 10 minutes, and 
then washed twice.  Fixed cells were blocked with 5% BSA or 5% FBS for 1 hour at 
room temperature or overnight at 4C prior to incubation with appropriate primary 
antibodies: anti-GM130 (BD Biosciences, catalogue no. 610822, dilution 1:400); 
anti-GRASP65 (Abcam, catalogue no. ab30315, dilution 1:500); anti-HA (Cell 
Signaling Technology, catalogue no. 2367, dilution 1:400), anti-vinculin (Sigma-
Aldrich, catalogue no. V9131, dilution 1:400); anti-ARF6 (Abcam, catalogue no. 
ab77581, dilution 1:200); Anti-COP (Abcam, catalogue no. ab2899, dilution 1:200); 
Anti-non muscle myosin-IIA (Sigma-Aldrich, catalogue no. M8064, dilution 1:800). 
Cells were washed thrice with PBS and incubated with Alexa Fluor-conjugated 
secondary antibodies (Thermo Fisher Scientific) for 1 hour at room temperature 
followed by three washes in PBS.   Actin staining was carried out using either Alexa 
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Fluor 488 Phalloidin (Thermo Fisher Scientific), Phalloidin-TRITC (Sigma-Aldrich) 
or Alexa Fluor 647 Phalloidin (Thermo Fisher Scientific).  
 
Matrix degradation assay 
50% sulphuric-acid-washed coverslips were coated with 50 mg/ml poly-D-Lysine 
for 30 minutes at room temperature, and then fixed with 0.5% glutaraldehyde for 
15 minutes. 0.2% gelatin warmed at 37C was mixed with Oregon Green 488 
conjugated-pig gelatin at 6:1 ratio. Coverslips were coated with gelatin mix for 10 
minutes, washed with 1xPBS and then quenched with 5mg/ml sodium borohydride 
for 15 minutes followed by numerous washes. For matrix degradation assay, MEFs 
were seeded on these coated coverslips for 4 hours and then fixed for 
immunofluorescence imaging as described above. Dark spots corresponding to 
areas of cells indicate degradation of the matrix.  
 
Live cell imaging and microscopy 
 
Cells were imaged in complete medium (unless stated otherwise) at an acquisition 
rate from 5 seconds to 1 minute intervals using a spinning-disc confocal microscope 
(PerkinElmer Ultraview VoX) attached to an Olympus IX81 inverted microscope, 
equipped with a 100x oil immersion objective (1.40 NA, UPlanSApo), an EMCCD 
camera (C9100-13, Hamamatsu Photonics) for image acquisition, and Volocity 
software (PerkinElmer) to control the acquisition protocol. Fixed samples and live 
imaging were also imaged with a Nikon confocal A1R system and Nikon structured 
illumination microscopy (N-SIM) attached to a Nikon Ti-E inverted microscope with 
Perfect Focus System (PFS) using a 100x oil immersion objective (1.40 NA, CFI Plan-
ApochromatVC). The cameras, from Andor technology Neo sCMOS and DU-897 were 
used to acquire images for confocal A1R and N-SIM systems respectively, with the 
Nikon NIS-Elements AR software to control the acquisition protocol. For z stack 
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images, cells were imaged at a step-size of 0.2-0.5 m with a total height of 15-20 
m.  
 
Image processing and data analysis 
 
Image processing and analysis were performed with ImageJ or Volocity Software. 
The number of podosomes (marked by core or ring marker) was quantified 
automatically using an ImageJ-based tool for counting Nuclei (ImageJ plugin), which 
was manually verified for the first ten cells in the specimen to account for 
undetected podosomes (less than 10%). Line intensity measurements (arbitrary 
unit, a.u.) of GFP-ARNO, GFP-Cytohesin-1 and mCherry-UtrCH were quantified by 
measuring the mean intensity of GFP or mCherry fluorescence per area (m2), 
background subtracted and normalized with values ranging from 0 (lowest) to 1 
(highest).  
 
Statistical analyses 
 
Prism version 6 (GraphPad Software) was used to plot, analyze and represent the 
data. Significance of the differences was determined using two-tailed unpaired 
Student’s t-test or one-way ANOVA for more than two groups. The methods for 
statistical analysis and sizes of the samples (n) are specified in the results section or 
figure legends for all of the quantitative data. Differences were accepted as 
significant for P < 0.05.  
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Online supplementary material 
 
Fig. S1 shows that knockdowns of either ARF1 or ARNO prevent formation of 
podosomes in THP1 cells stimulated by PMA, while ARF6 is not involved in 
podosome formation. Fig. S2 shows that ARF1-containing puncta are positive for 
Rab11 but not for Rab6, Rab7 or Rab8. Fig. S3 shows that inhibition of -COP as well 
as ARF exchange factors GBF1, BIG1 and BIG2 do not lead to podosome disruption in 
TGF1-stimulated THP1 cells. In addition, ARF1-mediated pathway of podosome 
formation does not involve Cdc42. Fig. S4 shows dynamics of podosome 
disassembly by SecinH3 visualized using structured-illumination microscopy (SIM). 
Fig. S5 shows that cell treatment with the drugs suppressing ARF1 activity results in 
disruption of Src-induced podosome rosettes in fibroblasts, but does not disrupt 
focal adhesions. In addition, this figure shows actin-rich puncta in fibroblasts 
transfected with constitutively active ARF1 and localization of podosome core 
proteins to these puncta.  
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Figure Legends 
 
Figure 1 
 
Depletion of endogenous ARF1 disrupts podosomes. (A) Western blot showing 
ARF1 levels in cells treated with scramble (control) or ARF1 siRNA; -tubulin was 
used as a loading control. (B, C) ARF1 knockdown leads to disruption of podosomes 
but not the Golgi apparatus. Actin labeled with phalloidin (left panel) and vinculin 
visualized by antibody staining (right panel) in control (B) and ARF1 siRNA-
transfected (C) THP1 cells 48 h after TGF1 stimulation. The Golgi apparatus in the 
same cells was visualized by staining with antibody against cis-Golgi proteins, 
GM130 (left panel, green) and GRASP65 (right panel, red). Scale bars, 5 m.  (D) 
Expression of HA-tagged bovine ARF1 in ARF1-depleted human THP1 cells rescues 
podosome formation. Podosomes are visualized by phalloidin staining (left and right 
panels) and HA-ARF1 by immunostaining with anti-HA antibody (central and right 
panels). Scale bar, 5 m. HA-ARF1 was localized to Golgi and to punctate structures 
shown with high magnification in (D’) representing the enlarged area boxed in (D). 
Scale bar, 1 m. Labeling in (D’) shows actin (upper image), HA-ARF1(middle 
image), and merged image of both (lower panel).  Width of the images 7 m.  (E,F) 
Quantification of the effect of ARF1 and ARF6 knockdown on podosomes integrity. 
Both number of podosomes per cell (E) and percentage of cells having more than 10 
podosomes (F) decreased upon ARF1 but not ARF6 knockdown. This effect was 
rescued by expression of exogenous HA-ARF1. The graphs represent results of 3 
independent experiments with 100-200 cells used for each group. The numbers of 
podosomes per cell are presented as box-and-whiskers plot while the percentage of 
cells with more than 10 podosomes as mean ± SD. The significance of the difference 
between groups was estimated by two-tailed Student’s t-test, the range of P-values 
>0.05(non-significant), ≤ 0.05, ≤0.01, ≤0.001, ≤ 0.0001 are denoted by “ns”, one, two, 
three and four asterisks (*), respectively.    
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Figure 2 
 
Localization and dynamics of ARF1 puncta in TGF1-stimulated THP1 cells. (A) TIRF 
image of the ventral surface of cell with podosomes labeled by mCherry-vinculin 
(left panel) and ARF1 puncta labeled by GFP-ARF1 (central panel). Merged image 
(right panel) shows non-random distribution of ARF1 puncta with a tendency to co-
localize to podosome periphery. Scale bar, 5 m. Boxed area (2.5x2.5 m2) contains 
a podosome, where co-localization dynamics with ARF1 puncta is presented in (B). 
(B) Kymograph representing fluorescent intensities in a line scan through the 
podosome boxed in (A). While mCherry-vinculin is stably labeled in the podosome 
ring (upper panel), GFP-ARF1 was transiently concentrated at one side of the ring 
(central panel and merged image at the bottom). See also Supplementary movie 1. 
The time course of fluorescence intensity of GFP-ARF1 at the podosome ring is 
shown in (B’). (C) Each dot corresponds to a single cell and represents percentage of 
podosome rings (labeled by vinculin) contacted by either ARF1-containing puncta 
or Rab6-containing vesicles within 5 minutes of image acquisition. (D) Frequency 
distribution of the durations of podosome contacts (in seconds) with ARF1-
containing puncta (35 podosomes from 10 cells were filmed as shown in kymograph 
B). (E,F) GFP-ARF1 puncta are moving along microtubules. (E) Left panel: 
microtubule labeling with 125 kDa microtubule-associated protein, ensconsin 
(mCherry-ensconsin); central panel: GFP-ARF1 puncta in the same cell; right panel: 
merged imaged. The dynamics of microtubules and ARF1 puncta in the boxed area 
(8 x 7.5 m2) of C is shown in (F). Scale bar, 5 m. Movement of puncta along the 
microtubule is indicated by arrowhead. See also Supplementary movie 2. 
  
 
Figure 3 
 
ARF1-GTP levels and podosome formation. (A) Quantification of ARF1-GTP levels by 
G-LISA assay in control, stimulated and inhibitor-treated THP1 cells. Both TGF1 
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and PMA increased the fraction of GTP-bound ARF1 compared to control, while 
treatment with SecinH3 or BFA dramatically reduced it. Pooled results of 3 
independent experiments are shown. (B) Disruption of podosomes labeled with 
mCherry-Utrophin (UtrCH) upon treatment with SecinH3 (upper panel). Note that 
integrity of the Golgi apparatus labeled with GFP-mannosidase II was preserved in 
the same SecinH3-treated cell (lower panel). See also Supplementary movie 3. (C,D) 
Disruption of podosomes labeled with mCherry-vinculin by SecinH3 (upper panel of 
C) and BFA (upper panel of D). Whilst the effect of SecinH3 in these cells is not 
accompanied by changes in localization of ARF1 to the Golgi and cytoplasmic puncta 
(lower panel of C), BFA disrupted both Golgi and ARF1 puncta (lower panel in D); 
Scale bars, 5 m. Insets (1 x 1 m2) show evolution of individual ARF1 puncta in 
each case. (E,F) Quantification of the effect of SecinH3 and BFA on average number 
of podosomes per cell (E) and percentage of cells with more than 10 podosomes (F). 
(G) ARF1-GTP levels increase in fibroblasts plated on a RGD-functionalized fluid 
lipid bilayer as compared to fibroblasts plated on glass coverslip. (H) Effect of 
SecinH3 on the integrity of podosome-like structures formed by fibroblasts plated 
on fluid lipid bilayer. (I) Quantification of the disruptive effect of SecinH3 and BFA 
on podosome-like structures formed by fibroblasts on lipid bilayer. The percentage 
of podosome-forming cells significantly decreased upon treatment by each of the 
inhibitors. The data were presented and the significances of the difference were 
assessed as indicated in the legend to Figure 1. Pooled data of three independent 
experiments are presented for each group. 
 
Figure 4 
 
Knockdown of ARF1 exchange factor ARNO (cytohesin-2), but not cytohesin-1 leads 
to podosome disruption. (A) Western blot showing ARNO and cytohesin-1 levels in 
cells treated with control (scrambled) siRNA, ARNO or cytohesin-1 siRNAs; -
tubulin was used as a loading control. (B) Upper panel: TGF1-stimulated THP1 
cells; podosomes labeled with phalloidin and Golgi apparatus labeled by antibody 
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against GM130. Middle panel: siRNA-mediated knockdown of ARNO disrupted 
podosomes leaving the Golgi undisturbed. Lower panel: Cytohesin-1 knockdown 
disrupt neither podosomes nor Golgi.  Scale bars, 5 m.  (C,D) Quantification of the 
effect of ARNO and cytohesin-1 knockdowns on average number of podosomes per 
cell (C) and percentage of cells with more than 10 podosomes (D). (E) G-LISA 
quantification of ARF1-GTP level in non-transfected control cells, scrambled siRNA-
transfected cells, and cells transfected with ARNO siRNA. (F,G) Quantification of the 
effect of expression of wild-type GFP-ARNO and of dominant negative ARNO mutant 
(GFP-ARNO E156K) on average number of podosomes per cell (F) and percentage of 
cells with more than 10 podosomes (G). The data were presented and the 
significances of the difference were assessed as indicated in the legend to Figure 1. 
Pooled data of three independent experiments are presented for each group. 
 
Figure 5 
 
ARNO but not cytohesin-1 is localized to podosomes and podosome-like structures 
in different cell types. (A,B,C) Localization of F-actin marker, mCherry-UtrCH and 
GFP-ARNO in TGF1-stimulated THP1 cell (A), active Src-transformed fibroblast (B) 
and fibroblast on a RGD-functionalized fluid lipid bilayer (C). Left panels: F-actin 
cores of podosomes (A), podosome rosettes (B), and podosome-like structures 
formed on fluid bilayer (C). Central panels: GFP-ARNO localized to periphery of F-
actin cores (A,B,C). Right panels: merged images. The boxed areas (A and B: 2.5 x 2.5 
m2, Scale bar: 1 m, C: 14 x 14 m2, Scale bar, 5 m) of merged images are enlarged 
and line scanned as shown in inset. The graphs on the right demonstrate intensity 
profiles of F-actin and ARNO in individual podosome (A), podosome “rosette” (B), 
and podosome-like structure on bilayer (C). (D, D’) Time course of ARNO 
localization to the podosome periphery. Dynamics of F-actin (labeled by mCherry-
UtrCH) and GFP-ARNO fluorescence intensities in the podosome shown in the boxed 
area (3 x 3 m2) in D are presented in the sequences in D’. Time interval between 
frames is 30 seconds. See also Supplementary movie 6. (E) Cytohesin-1 is not 
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localized to podosomes.  Left panel: F-actin cores of podosomes in TGF1-
stimulated THP1 cell. Central panel: GFP-cytohesin-1 localization in the same cell. 
Right panel: merged image. Line scanning through the individual podosome in the 
boxed area (4 x 1.5 m2) of the merged image shown in inset is quantified in the 
graph on the right. No enrichment of GFP-cytohesin-1 at podosome core or 
periphery was detected. Scale bars, 5 m.   
 
Figure 6 
 
Inhibition of ARF1 activity induces RhoA activation. (A-C) 1 hour incubation of 
TGF1-stimulated THP1 cells with 30 M SecinH3 led to increase in RhoA-GTP (A) 
but not Rac1-GTP (B) or Cdc42-GTP (C) fractions as indicated by western blots after 
pull-down assay. (D-J) Structured-illumination microscopy (SIM) visualization of 
podosome dynamics in TGF1-stimulated THP1. (D and E) Live imaging of cell 
stably transfected with GFP-MRLC to visualize myosin-II filaments and RFP-lifeact to 
visualize podosome cores.  (D) Cell treated with 30 M SecinH3 show an increase in 
myosin-IIA filament assembly (green) and disruption of podosomes (red). Enlarged 
image of white-boxed area (5 x 4.5 m2) of D shows co-localization between 
appearance of myosin-IIA filaments and podosome disruption (See supplementary 
movie 7). (E) Time course of podosome re-appearance after addition of 30 M ROCK 
inhibitor Y-27632 to cell incubated in secinH3 containing medium. Note that 
podosomes (red) appeared after disassembly of myosin-II filaments (green).  (F-J)  
TGF1-stimulated THP1 cells were transfected with either control scrambled siRNA 
(F and G) or with siRNA to NM-myosin-IIA heavy chain, MYH9 (I and J) and, after 48 
hours, treated with either 0.1% DMSO (F and I) or 30 M SecinH3 (G and J) for 1 
hour. (F, G, I, J) After fixation, the cells were stained with phalloidin (left panels) and 
antibodies to NM-myosin-IIA heavy chain (middle panels) and vinculin (right 
panels). (H) Western blot showing protein levels of NM-myosin-IIA heavy chain in 
control cells (transfected with scrambled siRNA) or in NM-myosin-IIA knockdown 
cells (transfected with MYH9 siRNA); -tubulin was used as a loading control. (K 
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and L) Effect of secinH3 treatment of control and NM-myosin-IIA knockdown cells 
on the average number of podosomes per cell (K) and percentage of cells with more 
than 10 podosomes (L). The data are presented as indicated in the legend to Figure 
1. Pooled data of at least two independent experiments are presented for each 
group. 
 
Figure 7 
 
Constitutively active ARF1 induces F-actin-rich puncta (labeled by mCherry-UtrCH) 
in mouse fibroblasts. (A) Transfection with wild-type CFP-ARF1 did not change actin 
cytoskeleton of fibroblast. (B) Numerous F-actin-rich puncta in the fibroblast 
transfected with constitutively active ARF1 mutant, CFP-ARF1 Q71L. Scale bars, 5 
m.  (B’) Images of the boxed area (6 x 4.5 m2) in (B) showing F-actin (red, upper 
row), CFP-ARF1 Q71L (green, middle row), and their superimposition (lower row) 
at 3 time points taken with a 3 second time interval are presented. Transient 
contacts (yellow) of CFP-ARF1 Q71L-containing puncta with the F-actin-rich puncta 
are seen. Scale bar, 1 m.  (C) Cell transfected with dominant negative RhoA (GFP-
RhoA T19N) do not contain stress fibres. (D) Cell co-transfected with dominant 
negative RhoA (GFP-RhoA T19N) and constitutively active ARF1 (CFP-ARF1 Q71L) 
form numerous F-actin-rich puncta. (E) Control fibroblast forming stress fibres 
(left) does not demonstrate localization of mCherry-WIP (right).  (F) F-actin-rich 
puncta in fibroblast expressing CFP-ARF1 Q71L are enriched with mCherry-WIP. (G 
and H) Fibroblasts transfected with constitutively active ARF1 (CFP-ARF1 Q71L) 
were plated on fluorescent gelatin-coated coverslips in the control medium 
containing 0.2% DMSO (G) or in the medium containing 25 M MMP inhibitor 
GM6001 (H) and incubated for 4 hours. The matrix degradation sites in the boxed 
areas are seen at high magnification in the left panel of G’ but not H’. Actin puncta 
were visualized by phalloidin staining; high magnifications of boxed areas in G and 
H as well as merged images of actin and fluorescent gelatin are shown in central and 
right panels of G’ and H’ respectively. Note that actin puncta co-localize with dark 
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areas corresponding to degraded fluorescent gelatin in control fibroblasts (white 
arrowheads in G’), while gelatin degradation is completely prevented in cells treated 
with GM6001 (H’).  Scale bars, 5 m.  
 
Figure 8 
 
A flow diagram illustrating the role of ARNO-ARF1 signaling axis in the podosome 
formation. A variety of external factors known to switch cells towards podosome 
formation activate the ARF GEF ARNO. The ARNO activates ARF1, which in turn 
induce two major pathways regulating the podosomes. First, ARF1 inhibits Rho, 
which negatively regulate podosomes via ROCK-dependent formation of myosin-II 
filaments. Second, ARF1 promotes formation of Arp2/3- and actin-enriched 
podosome core-like structures associated with matrix degradation sites. The solid 
arrows represent the direct pathways while the dashed arrows indicate to the 
existence of unknown intermediate steps in the depicted pathways.  
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